LOEROP JAMES (Chief Business Officer) exercised options at ACLARIS THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 2 exercises
Filed: 1/5/2026ACC: 0001781549-26-000003
Officer· Chief Business Officer
Since Jan 2022
-40.16K
Net shares
Net seller
$120.1K
Total sold
0
Open market trades
0B · 0S
6
Total transactions
91.90K acquired · 132.06K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+73.75K
Price / share
—
Trade value
—
% of position
71.4%
12/31/2025
103.31K→177.06K
Common Stock
Direct
Shares
−33.99K
Price / share
$3.01
Trade value
$102.32K
% of position
19.2%
12/31/2025
177.06K→143.06K
Common Stock
Direct
Shares
+18.15K
Price / share
—
Trade value
—
% of position
12.7%
1/2/2026
143.06K→161.21K
Common Stock
Direct
Shares
−6.17K
Price / share
$2.88
Trade value
$17.77K
% of position
3.8%
1/2/2026
161.21K→155.04K
Total
Net shares
+51.73K
Net value
-$120.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2025 | M · Option Exercise | +73.75K | — | — | 71.4% | 103.31K | 177.06K |
| Common Stock Direct | 12/31/2025 | F · Tax Withholding | −33.99K | $3.01 | $102.32K | 19.2% | 177.06K | 143.06K |
| Common Stock Direct | 1/2/2026 | M · Option Exercise | +18.15K | — | — | 12.7% | 143.06K | 161.21K |
| Common Stock Direct | 1/2/2026 | F · Tax Withholding | −6.17K | $2.88 | $17.77K | 3.8% | 161.21K | 155.04K |
| Total | +51.73K | -$120.09K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
73.75K shares
Shares
−73.75K
Strike price
Held after
0.00
Exercisable
—
12/31/2025
Restricted Stock Units
Direct
Converts to
Common Stock
18.15K shares
Shares
−18.15K
Strike price
Held after
18.70K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock73.75K shares | 12/31/2025 | M · Option Exercise | −73.75K | — | 0.00 | |
| Restricted Stock Units Direct | Common Stock18.15K shares | 1/2/2026 | M · Option Exercise | −18.15K | — | 18.70K |